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ABSTRACT: Asthma is a prevalent disease in doctor offices and 
Pneumology outpatient clinics and it reaches different age groups. 
The control of the disease aims to improve the quality of life of 
the patient and to avoid complications. It is done using drugs 
with anti-inflammatory and bronchodilator properties and by the 
control of environmental factors, possible triggers of asthmatic 
crises. However, the influence of psychological conditions on this 
control is hardly mentioned. Anxiety and depressive disorders 
are very prevalent nowadays and there is a lot of evidence that 
they have a strong influence on asthma control. In order to assess 
the prevalence of depressive symptoms and anxiety in patients 
with asthma and to analyze the impact they have in asthma 
control, an observational, descriptive, and cross-sectional study 
was carried out from April 2019 to March 2020 with asthma 
patients treated at pneumology outpatient clinic of the Faculdade 
Ciências Médicas de Minas Gerais, in Belo Horizonte (MG). Forty 
patients participated in the study, who answered two validated 
questionnaires (HADS - Hospital Anxiety and Depression Scale 
and ACT - Asthma Control Test) and provided demographic and 
spirometric values. The results showed that there is an association 
between asthma control and psychiatric disorders. The prevalence 
of anxiety and/or depression disorders among the total sample was 
75%, and anxiety was more prevalent. Among those considered 
to have uncontrolled asthma, the disorders were present in 92%, 
whereas among those with controlled asthma the prevalence was 
47%. However, there was no significant association between age, 
sex, spirometric values, and asthma control. At the end of the 
study, it was not possible to clearly define a cause-consequence 
relation between asthma control and psychiatric disorders, despite 
the evident relationship found between them, and therefore further 
studies on the topic are necessary.
Keywords: Asthma; Anxiety disorders; Depressive disorder; 
Anxiety; Depression; Cross-sectional studies.
RESUMO: A asma é uma doença prevalente nos ambulatórios e 
consultórios de Pneumologia, atingindo faixas etárias variadas. O 
controle da doença visa melhorar a qualidade de vida do portador 
e evitar complicações, sendo feito através do uso de medicações 
anti-inflamatórias e broncodilatadoras e do controle de fatores 
ambientais, possíveis gatilhos das crises. No entanto, pouco se 
fala a respeito da influência das condições psicológicas sobre esse 
controle. O transtorno de ansiedade e o transtorno depressivo são 
muito prevalentes na atualidade e existem diversas evidências 
de que exercem forte influência no controle da asma. Com o 
objetivo de avaliar a prevalência de sintomas depressivos e de 
ansiedade em pacientes portadores de asma e analisar o impacto 
destes no controle da doença, foi realizado um estudo transversal, 
observacional, descritivo no período de abril de 2019 a março 
de 2020 envolvendo asmáticos atendidos no ambulatório de 
Pneumologia da Faculdade Ciências Médicas de Minas Gerais, 
em Belo Horizonte (MG). Participaram do estudo 40 pacientes, 
que responderam a dois questionários validados (HADS - Hospital 
Anxiety and Depression Scale e ACT - Asthma Control Test) e dos 
quais foram coletados dados demográficos e espirométricos. Os 
resultados mostraram a existência de associação entre o controle da 
asma e os transtornos psiquiátricos. A prevalência de transtornos 
de ansiedade e/ou depressão na totalidade da amostra foi de 75%, 
sendo o de ansiedade o mais prevalente. Entre os portadores de 
asma não controlada, os transtornos estavam presentes em 92%, 
ao passo que entre aqueles com asma controlada a prevalência 
foi de 47%. Não houve, no entanto, associação significativa entre 
idade, sexo, alterações espirométricas e o controle da asma. Ao 
final do estudo, não foi possível definir claramente a relação 
causa-consequência entre controle da asma e os transtornos 
psiquiátricos, apesar da evidente associação encontrada, sendo 
necessário, portanto, novos estudos para tal.
Descritores: Asma; Transtornos de ansiedade; Transtorno 
depressivo; Ansiedade; Depressão; Estudos transversais.
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INTRODUCTION
Asthma is a chronic inflammatory disease characterized by hyperresponsiveness of the 
lower airways and variable limitation to airflow, reversible 
spontaneously or with treatment, manifesting clinically by 
recurrent episodes of wheezing, dyspnea, tightness in the 
chest, and cough, especially at night and in the morning 
upon awakening. It results from an interaction between 
genetics, environmental exposure, and other specific 
factors that lead to the development and maintenance of 
symptoms1,2.
The disease affects both children and adults, and 
it is a global health issue that affects about 300 million 
individuals. It is estimated that, in Brazil, there are 
approximately 20 million asthmatics, if a global prevalence 
of 10% is considered2,3. In 2013, there were 129,728 
hospitalizations and 2,047 deaths from asthma in Brazil 1.
Hospitalizations and mortality from asthma 
are decreasing in many Brazilian regions, in parallel 
with greater access to treatments. However, the cost of 
uncontrolled asthma is still remarkably high for the health 
system and families. Cases of severe asthma are estimated 
to affect more than a quarter of the family income among 
users of the Sistema Único de Saúde (SUS), but this high 
cost can be significantly reduced with adequate disease 
control. However, a national survey found only 12.3% of 
asthmatics with well-controlled asthma1.
Disease control refers to the extent to which asthma 
manifestations are suppressed, either spontaneously or 
by treatment, and comprises two distinct domains: the 
control of current clinical limitations and the reduction of 
future risks (reduction of asthma instability, exacerbations, 
accelerated loss of lung function and adverse treatment 
effects). This control should preferably be evaluated 
concerning the last four weeks, and it includes symptoms, 
needs for relief medication, limitation of physical activities, 
and intensity of limitation to airflow. Currently, in addition 
to the Global Initiative for Asthma (GINA)3 asthma control 
questionnaire, other tools are available, which have already 
been culturally adapted for Brazil, including the Asthma 
Control Questionnaire (ACQ) and the Asthma Control 
Test (ACT). From these questionnaires, asthma can be 
classified into three distinct groups: controlled asthma, 
partially controlled asthma, and uncontrolled asthma. When 
not controlled, however, asthma can seriously limit daily 
activities and it can even be fatal1,2.
To improve control, it is important to identify and 
try to reduce factors capable of intensifying symptoms or 
precipitating exacerbations of asthma, among which we can 
mention the lack of treatment adherence; the incorrect use 
of medication and/or inhalation devices; the use of drugs 
that can decrease the response to treatment (non-steroidal 
anti-inflammatory drugs and β-blockers); home exposure 
(for example, dust or smoke); occupational exposure; 
smoking; and other comorbidities1.
Evidence indicates that emotional disorders 
can induce an inadequate control of asthmatic disease, 
influencing, for example, the reduction of quality of life, the 
increase in hospitalizations, the worsening of symptoms, 
the need for higher doses of inhaled corticosteroids, the 
difficulty adherence to treatment and even the precipitation 
of lethal crises4,5.
Depression, along with anxiety, presents itself as 
an important cause of disability in the world, limiting 
physical, personal, and social functioning. In primary care 
clinics, the prevalence of depression was estimated at 5% 
to 10% of all patients, and only one in a hundred mentions 
the disease as the reason for the consultation. Up to 50% 
of the time, the problem is not detected by professionals. 
Studies have established a correlation between a depressive 
and anxious state with the worsening of several clinical 
conditions, such as asthma6.
Although the relationship between asthma and 
psychological suffering is still not well understood, there 
is a study that shows4 the existence of such a correlation. 
There has already been suggested a hypothesis that 
chronic psychological stress leads to the development of 
a pro-inflammatory state, with increased production of 
superoxide and pro-inflammatory cytokines4. However, the 
evidence-based guidelines for asthma do not yet provide 
a detailed outline for a good approach, screening, and 
diagnosis of anxiety and depression. For this to change, 
further studies and research on the topic need to be carried 
out to corroborate and elucidate the relationship between 
mood disorders, especially depression and anxiety, with 
uncontrolled asthma.
In this context, the present study was carried out 
to corroborate the idea that a multidimensional approach, 
including assessment of mental status, should be considered 
for asthmatic patients to improve that patient’s quality of 
life.
CASUISTICS AND METHODS
This is a descriptive, observational, cross-sectional 
epidemiological study, conducted from April 2019 to March 
2020 at the Ambulatório de Pneumologia da Faculdade 
de Ciências Médicas de Minas Gerais (FCM-MG), in 
Belo Horizonte (MG), Brazil. The research protocol was 
approved by the local ethics committee under the number 
CAAE 06386818000005134 and all study participants 
signed an informed consent form.
Overall, the study involved the participation of 40 
patients, who were allocated according to the following 
eligibility criteria: age equal to or greater than 18 years; 
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asthmatic patients previously diagnosed at least one year 
ago through spirometry available at the time of assessment; 
patients who were followed up at the Pulmonology of the 
Outpatient Clinic of FCM-MG for at least three months. 
The study did not include patients who refused to participate 
or who were unable to answer the questionnaires; carriers 
of other pulmonary disorders (Chronic Obstructive 
Pulmonary Disease, sequelae of tuberculosis, pulmonary 
hypertension, or pulmonary fibrosis); patients with severe 
comorbidities (neoplasms, chronic renal failure, liver 
failure, autoimmune diseases, heart failure) and patients 
with known neuropsychic disorders, except for anxiety 
disorder and depressive disorder.
Eligible patients answered two validated 
questionnaires, the first of which was the ACT (Asthma 
Control Test) — a self-administered questionnaire with 
satisfactory reproducibility, useful for quantifying and 
evaluating asthma control and which was validated for 
this purpose. It consists of 5 questions, related to the four 
weeks preceding the assessment, addressing multiple 
dimensions of control, including episodes of shortness of 
breath, nighttime awakenings, limitations in daily activities, 
self-assessment of asthma control, and need for relief 
medication. Each question is scored on a 6-point scale - 
from 0 (good control) to 5 (bad control) - and, therefore, 
the total score ranges from 5 to 25. A score ≥ 20 on the 
ACT is defined as controlled asthma7.
The second questionnaire applied was the HADS 
(Hospital Anxiety and Depression Scale), widely used in 
the screening of psychiatric morbidity, which consists of 
14 questions — 7 for anxiety and 7 for depression, each 
scored from 0 to 3. The maximum score for anxiety or 
depression, therefore, is 21. Higher scores indicate more 
symptoms. An anxiety score ≥ 8 in HADS was considered a 
diagnosis of anxiety, while a depression score ≥ 9 in HADS 
was considered a diagnosis of depression4,13.
Finally, demographic data (age and sex) and 
spirometric data (FEV%, FVC%, FEV1, FVC, and 
FEV1 / FVC ratio were collected before and after the 
use of a short-acting inhaled β2-agonist), provided by 
the participants, was made, and analyzed according to 
the normal recommended by the Sociedade Brasileira de 
Pneumologia e Tisiologia15.
The data obtained were digitized in a Microsoft 
Excel 2010 spreadsheet and imported for statistical analysis 
in software R version 3.4.3. The numerical variables were 
presented as mean ± standard deviation and the categorical 
variables as absolute and relative frequencies (“n (%)”). To 
compare means between numerical variables, the Mann-
Whitney test was used and associations between categorical 
variables were assessed using the Chi-square test or Fisher’s 
exact test. The level of significance in all tests was 0.05.
RESULTS
Of the 40 study participants, 25 were females 
(62.5%) and 15 males (37.5%). Regarding age, the mean 
was 52.5 (± 15.9). 15 participants (37.5%) had controlled 
asthma and 25 (62.5%) had uncontrolled asthma, according 
to the ACT classification. The demographic and clinical 
characteristics of the sample are shown in Table 1.
Regarding the spirometry data, the average value 
found for the Final Expiratory Volume in relation to the 
predicted value (FEV1%) was 66.5 (± 19.4) and for the 
Tiffenau index (TIF) 0.7 (± 0 ,1). The complete spirometric 
data of the patients are shown in Table 2.









Age 52,5 ± 15,9 51,4 ± 18,6 53,1 ± 14,5 0,944 M
Sex
  Female 25 (62,5) 9 (60,0) 16 (64,0) > 0,999 Q
  Male 15 (37,5) 6 (40,0) 9 (36,0)
ACT Score 16,6 ± 5,2 22,0 ± 1,9 13,4 ± 3,5 < 0,001 M
M Mann-Whitney Test; Q Qui-square Test. Data are presented as mean ± standard deviation or absolute number (percentage). 
Source: prepared by the authors.
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    FEV1 2,1 ± 1,0 2,2 ± 1,0 2,0 ± 1,0 0,530
    FEV1 (% of predicted) 66,5 ± 19,4 67,8 ± 15,5 65,8 ± 21,6 0,675
    CVF 3,0 ± 1,2 3,2 ± 1,4 2,9 ± 1,1 0,494
    FVC (% of predicted) 74,7 ± 17,9 75,5 ± 18,6 74,2 ± 17,8 0,716
    TIF 0,7 ± 0,1 0,7 ± 0,1 0,7 ± 0,1 0,900
Post-BD
    FEV1 2,3 ± 1,0 2,4 ± 1,0 2,2 ± 1,0 0,557
    CVF 3,2 ± 1,2 3,3 ± 1,3 3,1 ± 1,2 0,485
    TIF 0,7 ± 0,1 0,7 ± 0,1 0,7 ± 0,1 0,566
MMann-Whitney test. Data are presented as mean ± standard deviation. Caption: BD: Bronchodilator; FEV1: Forced Expiratory Volume in the first 
second, FVC: Forced Vital Capacity, TIF: Tiffenau index. Source: prepared by the authors.
It should be noted that there was no significant 
association between sex, age, and spirometry measures with 
asthma control classified according to the ACT (p> 0.05).
Of the 40 patients in the sample, 10 had none of 
the two mood disorders assessed according to the HADS 
score, 17 had anxiety, 7 depression, and 6 the binomial 
anxiety/depression.
There was a significant association (p <0.05) 
between asthma control and symptoms of anxiety and/or 
depression. The prevalence of mood disorders among the 
40 patients in the sample was 75%, and isolated anxiety 
disorder was the most common. Of the 15 controlled 
asthmatic patients (ACT 20), 8 (53%) did not present a 
mood disorder. Among the 25 patients with uncontrolled 
asthma (ACT <20), only 2 (8%) were considered to have 
no anxiety and/or depression. Among the group of patients 
with uncontrolled asthma and patients with mood disorders, 
12 (48%) had anxiety, 6 depression (24%) and 5 had 
binomial anxiety and depression (30%). The correlation 
between mood disorders and asthma control is shown in 
Table 3 and Graphs 1 and 2.









Symptoms of anxiety and depression 0,014
   None 10 (25,0) 8 (53,3) 2 (8,0)
   Anxiety 17 (42,5) 5 (33,3) 12 (48,0)
   Depression 7 (17,5) 1 (6,7) 6 (24,0)
   Anxiety and Depression 6 (15,0) 1 (6,7) 5 (20,0)
F Fisher’s exact test. Data are presented as mean ± standard deviation or absolute number (percentage). Source: prepared by the authors
Graph 1 - Correlation between asthma control and mood disorders
Source: prepared by the authors
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     Graph 2 - Correlation between asthma control and mood disorders
Source: prepared by the authors
DISCUSSION
Supporting the epidemiological statistics that point 
out that the prevalence of asthma is higher in females 
among adults6, the women in the study constitute most of 
the sample (62.5%). As asthma is a multifactorial disease, 
in which genetic, environmental, pathophysiological, and 
immunological factors are involved, the reasons for gender-
specific differences can also be multiple, such as differences 
in airway physiology and pathology and behavioral 
differences between both sexes. However, the hormonal 
factor seems to be a fundamental component to understand 
this dissimilarity. Approximately 20-40% of asthmatic 
women report worsening of respiratory symptoms during 
the premenstrual and menstrual periods. The mechanism of 
worsening asthma in the menstrual cycle is still unknown, 
but it has been suggested to reduce serum progesterone 
levels, increase mucous secretions, increase the synthesis 
of prostaglandins in the premenstrual period, and alter the 
regulation of the receptor β2-adrenergic9.
Several studies show a preponderance of asthma 
in childhood, with a decline in young adults and a second 
increase in those over 60 years of age8. The study was 
conducted with adult participants (> 18 years), with an 
average age of 52.5 (± 15.9), according to the statistics.
As previously noted in the results, there was no 
significant association between sex, age, and asthma 
control. However, a study published in 2014 counters this 
finding9. It shows that women’s perception of asthma is 
different from men’s perception and the results suggest 
that women with asthma experience greater impact 
and frequency in their respiratory symptoms and more 
commonly experience limitations in daily life caused by 
asthma than men. Following this line of reasoning, it was 
expected that uncontrolled asthma would be more prevalent 
in the women in the study, since the classification of asthma 
by the ACT takes into consideration the self-perception of 
symptoms, activity limitations, and disease control, which 
did not occur, however.
The GINA (Global Initiative for Asthma)3, considered 
the main global guideline for asthma management, 
takes into consideration daytime symptoms, nocturnal 
awakenings, frequency of rescue medication use, and 
activity limitation to classify asthma control. However, the 
document does not consider FEV% as a control parameter, 
although it is deemed a risk factor for future exacerbations 
when <60%. Therefore, it is assumed that asthma control 
is closely related to the patient’s perception of the impact 
of the disease on his or her daily life; thus, psychological 
factors, such as anxiety and depression, can have a strong 
influence on asthma control. The results of the present study 
corroborate this since no significant association (p > 0.05) 
was found between spirometric data and asthma control.
Several studies have shown the high prevalence of 
psychiatric disorders, especially anxiety and depression, as 
well as post-traumatic stress disorder, in asthma patients10. 
The findings of the present study confirm this fact. Of the 
40 participating asthmatic patients, 30 had anxiety and/
or depression, which represents 75% of the sample. The 
isolated anxiety disorder was the most prevalent (57%), 
followed by the isolated depressive disorder. The anxiety/
depression binomial was found in a smaller number of 
participants.
As previously elucidated, there was a significant 
association (p < 0.05) between asthma control and 
symptoms of anxiety and/or depression, showing that the 
presence of mood disorders influences asthma disease 
control. Regarding this as the focus of the study, hypotheses 
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for such an association are raised.
The first is that psychiatric disorders intensify the 
inflammation inherent in asthma. Although there is little 
documented data on how this occurs, it is hypothesized 
that psychological stress causes a cholinergically mediated 
increase in airway reactivity, as well as stimulating 
the release of pro-inflammatory cytokines such as the 
interleukins IL-2, IL-4, IL-8, and IL-33 and transforming 
growth factor (TGF-β), which are involved in the 
inflammatory response in asthma, as was shown in a study 
conducted in 201714. The systemic inflammatory process 
generated by chronic psychic disorders may also be able 
to cause alterations in the small pulmonary airways, at 
the level of bronchioles, alveoli, and perivascular spaces, 
whose chronic affection is responsible for severe and 
difficult-to-manage asthma17.
A second hypothesis would be that mood disorders 
alter asthma patients’ awareness of their disease, increasing 
the perception of symptoms and reducing the perception of 
the level of control10. This would justify low ACT scores, 
increasing the number of asthma patients considered to be 
uncontrolled. Moreover, respiratory symptoms secondary 
to mood disorders — in the case of anxiety, a feeling of 
breathlessness, and increased heart rate, and in the case 
of depression, insomnia, and fatigue — may overlap with 
those of asthma4, underestimating asthma control. Anxiety 
and depression in asthma patients can also be responsible 
for reducing their adherence to asthma treatment since they 
often present clinically with demotivation, pseudodementia, 
and memory lapses. A patient who is less adherent to regular 
treatment has consequently less control of the disease.
Another point to consider is the fact that dyspnea 
is one of the most limiting symptoms in patients with 
asthma and it can also be seen as one of the most important 
factors in determining the severity and quality of life of 
patients with the disease. There are several factors related 
to the origin of asthma dyspnea, including hypoxemia, 
hypercapnia, and increased respiratory effort. In this sense, 
the hypothesis raised is that the hyperventilation which 
occurs in anxiety attacks may lead to systemic hypoxemia 
and pulmonary hypoxia and, consequently, to the symptom 
of dyspnea reported by the patient. Therefore, perhaps, 
it was observed in the present study that uncontrolled 
asthmatics had a higher prevalence of anxiety symptoms16.
On the other hand, it has also been postulated that 
poorly controlled asthma leads to an increase in anxiety 
and depression symptoms for reasons that have not yet 
been elucidated in the literature. It is worth mentioning that 
since this is a cross-sectional study it is difficult to define 
whether anxiety and depression disorders are the cause or 
the consequence of uncontrolled asthma, despite the clear 
association between them.
Another limitation of the study was the small sample 
size due to the difficulty in finding participants who met all 
the eligibility criteria. Thus, the results of this study may 
limit the external validity of the result obtained. 
Despite the limitations, the main hypothesis of the 
study that there is a correlation between asthma uncontrol 
and the concomitant presence of anxiety disorder and/or 
depression was corroborated.
CONCLUSION 
The results of the present study suggest the existence 
of an association between depressive and anxiety disorders 
and asthma control. Therefore, the professionals who 
monitor patients with asthma must be aware of this fact 
to improve the management of these patients, directing 
them, when necessary, to psychiatric and/or psychological 
monitoring concomitantly with the conventional clinical 
monitoring of asthma.
Because of the evidence shown, we infer that it is 
important to consider screening for depressive disorder 
and anxiety disorder in the approach to asthma in adults. 
With this, it is possible to minimize the unfavorable 
evolutions and outcomes for patients with the disease, 
such as limitation of daily activities, exacerbations, and 
hospitalizations to improve their quality of life and reduce 
the burden and expenses of the public health system and the 
private system with avoidable hospitalizations. Finally, we 
conclude that it is important that the theme discussed here 
is addressed and studied by more researchers to expand and 
consolidate information and data on the subject.
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